SNP 203
Alternative Names: SNP-203Latest Information Update: 22 Apr 2023
At a glance
- Originator SciNeuro Pharmaceuticals
- Class Antidementias
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis; Dementia
Most Recent Events
- 12 Apr 2023 Discontinued for Amyotrophic lateral sclerosis in China (unspecified route)
- 12 Apr 2023 Discontinued for Dementia in China (unspecified route)
- 22 Aug 2022 Early research in Amyotrophic lateral sclerosis in China (unspecified route) before August 2022